Normal Dendritic Cell Mobilization to Lymph Nodes under Conditions of Severe Lymphatic Hypoplasia

To address the requirement for lymphatic capillaries in dendritic cell (DC) mobilization from skin to lymph nodes (LNs), we used mice bearing one inactivated allele of vascular endothelial growth factor receptor 3 (VEGFR3) where skin lymphatic capillaries are reported absent. Unexpectedly, DC mobilization from the back skin to draining LNs was similar in magnitude, and kinetics to control mice and humoral immunity appeared intact. By contrast, DC migration from body extremities, including ear and forepaws, was ablated. An evaluation in different regions of skin revealed rare patches of lymphatic capillaries only in body trunk areas where migration was intact. That is, whereas the ear skin was totally devoid of lymphatic capillaries, residual capillaries in the back skin were present though retained only at ∼10% normal density. This reduction in density markedly reduced the clearance of soluble tracers, indicating that normal cell migration was spared under conditions when lymphatic transport function was poor. Residual lymphatic capillaries expressed slightly higher levels of CCL21 and migration of skin DCs to LNs remained dependent on CCR7 in Chy mice. DC migration from the ear could be rescued by the introduction of a limited number of lymphatic capillaries through skin transplantation. Thus, the development of lymphatic capillaries in the skin of body extremities was more severely impacted by a mutant copy of VEGFR3 than trunk skin, but lymphatic transport function was markedly reduced throughout the skin, demonstrating that even under conditions when a marked loss in lymphatic capillary density reduces lymph transport, DC migration from skin to LNs remains normal.

[1]  R. Neville,et al.  Supplemental surgical treatment to end stage (stage IV-V) of chronic lymphedema. , 2008, International angiology : a journal of the International Union of Angiology.

[2]  N. Romani,et al.  Expression of Langerin/CD207 reveals dendritic cell heterogeneity between inbred mouse strains , 2008, Immunology.

[3]  Seppo Ylä-Herttuala,et al.  Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3 , 2001, Nature Medicine.

[4]  G. Schmid-Schönbein,et al.  Microlymphatics and lymph flow. , 1990, Physiological reviews.

[5]  G. Schuler,et al.  Human cutaneous dendritic cells migrate through dermal lymphatic vessels in a skin organ culture model. , 1996, The Journal of investigative dermatology.

[6]  S. Halle,et al.  Afferent lymph–derived T cells and DCs use different chemokine receptor CCR7–dependent routes for entry into the lymph node and intranodal migration , 2011, Nature Immunology.

[7]  Melody A. Swartz,et al.  Transmural Flow Modulates Cell and Fluid Transport Functions of Lymphatic Endothelium , 2010, Circulation research.

[8]  J. Girard,et al.  Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules , 2011, Nature.

[9]  R. Steinman,et al.  Migration and maturation of Langerhans cells in skin transplants and explants , 1990, The Journal of experimental medicine.

[10]  D. Jäger,et al.  The Leukotriene C4 Transporter MRP1 Regulates CCL19 (MIP-3β, ELC)–Dependent Mobilization of Dendritic Cells to Lymph Nodes , 2000, Cell.

[11]  A. D. Van den Abbeele,et al.  Return of lymphatic function after flap transfer for acute lymphedema. , 1999, Annals of surgery.

[12]  G. Thorbecke,et al.  Antigen-bearing langerhans cells in skin, dermal lymphatics and in lymph nodes. , 1976, Cellular immunology.

[13]  Seppo Ylä-Herttuala,et al.  Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. , 2005, The Journal of clinical investigation.

[14]  E. Wolf,et al.  CCR7 Coordinates the Primary Immune Response by Establishing Functional Microenvironments in Secondary Lymphoid Organs , 1999, Cell.

[15]  R. Erickson,et al.  Chy‐3 mice are Vegfc haploinsufficient and exhibit defective dermal superficial to deep lymphatic transition and dermal lymphatic hypoplasia , 2007, Developmental dynamics : an official publication of the American Association of Anatomists.

[16]  A. Rudensky,et al.  In Vivo Analysis of Dendritic Cell Development and Homeostasis , 2009, Science.

[17]  PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. , 2005, Genes & development.

[18]  M. Sixt,et al.  Preformed portals facilitate dendritic cell entry into afferent lymphatic vessels , 2009, The Journal of experimental medicine.

[19]  U. Yrlid,et al.  Intestinal CD103− dendritic cells migrate in lymph and prime effector T cells , 2012, Mucosal Immunology.

[20]  R. Kauppinen,et al.  A model for gene therapy of human hereditary lymphedema , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[21]  F. Boccardo,et al.  Microsurgery for lymphedema: Clinical research and long‐term results , 2010, Microsurgery.

[22]  Alberto Smith,et al.  Lymphatic Dysfunction, Not Aplasia, Underlies Milroy Disease , 2010, Microcirculation.

[23]  N. Romani,et al.  Visualization and characterization of migratory Langerhans cells in murine skin and lymph nodes by antibodies against Langerin/CD207. , 2003, The Journal of investigative dermatology.

[24]  C. Halin,et al.  Tissue inflammation modulates gene expression of lymphatic endothelial cells and dendritic cell migration in a stimulus-dependent manner. , 2011, Blood.

[25]  D. Zawieja,et al.  Molecular Regulation of Lymphatic Contractility , 2008, Annals of the New York Academy of Sciences.

[26]  Akiko Iwasaki,et al.  CD4+ T cells support cytotoxic T lymphocyte priming by controlling lymph node input , 2011, Proceedings of the National Academy of Sciences.

[27]  K. Burnand,et al.  Milroy disease and the VEGFR-3 mutation phenotype , 2005, Journal of Medical Genetics.

[28]  K. Alitalo,et al.  Functional interaction of VEGF‐C and VEGF‐D with neuropilin receptors , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  Kurt Ballmer-Hofer,et al.  Neuropilin-1 promotes VEGFR-2 trafficking through Rab11 vesicles thereby specifying signal output. , 2011, Blood.

[30]  F. Ginhoux,et al.  Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state , 2007, The Journal of experimental medicine.

[31]  K. Alitalo,et al.  Impaired Humoral Immunity and Tolerance in K14-VEGFR-3-Ig Mice That Lack Dermal Lymphatic Drainage , 2012, Journal of Immunology.

[32]  B. Morris,et al.  The traffic of cells through tissues: a study of peripheral lymph in sheep. , 1970, Journal of anatomy.

[33]  P. Streeter,et al.  The influence of afferent lymphatic vessel interruption on vascular addressin expression , 1991, The Journal of cell biology.

[34]  Elisabetta Dejana,et al.  Functionally specialized junctions between endothelial cells of lymphatic vessels , 2007, The Journal of experimental medicine.

[35]  Mark J. Miller,et al.  Neutrophils Influence the Level of Antigen Presentation during the Immune Response to Protein Antigens in Adjuvants , 2010, The Journal of Immunology.

[36]  S. Rockson Causes and consequences of lymphatic disease , 2010, Annals of the New York Academy of Sciences.

[37]  G. Schuler,et al.  An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. , 1999, Journal of immunological methods.

[38]  A. Bollinger,et al.  Aplasia of superficial lymphatic capillaries in hereditary and connatal lymphedema (Milroy's disease). , 1983, Lymphology.

[39]  E. Kremmer,et al.  Lymph node T cell homeostasis relies on steady state homing of dendritic cells. , 2011, Immunity.

[40]  M. Karkkainen,et al.  Preexisting Lymphatic Endothelium but not Endothelial Progenitor Cells Are Essential for Tumor Lymphangiogenesis and Lymphatic Metastasis , 2004, Cancer Research.

[41]  Tatiana V. Petrova,et al.  Lymphangiogenesis in development and human disease , 2005, Nature.

[42]  F. Ginhoux,et al.  B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. , 2006, Immunity.

[43]  E. Devilard,et al.  The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells , 2007, The Journal of experimental medicine.

[44]  F. Tacke,et al.  Role of CCR8 and Other Chemokine Pathways in the Migration of Monocyte-derived Dendritic Cells to Lymph Nodes , 2004, The Journal of experimental medicine.

[45]  I TOEROE,et al.  [ON THE LYMPH NODES]. , 1964, Verhandlungen der Anatomischen Gesellschaft.

[46]  J. Villadangos,et al.  Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. , 2006, Immunity.

[47]  Melody A. Swartz,et al.  Dendritic-cell trafficking to lymph nodes through lymphatic vessels , 2005, Nature Reviews Immunology.

[48]  N L Tilney,et al.  Patterns of lymphatic drainage in the adult laboratory rat. , 1971, Journal of anatomy.

[49]  R. Steinman,et al.  Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. , 1999, Immunity.

[50]  Lai Guan Ng,et al.  DC mobilization from the skin requires docking to immobilized CCL21 on lymphatic endothelium and intralymphatic crawling , 2011, The Journal of experimental medicine.

[51]  T. Blankenstein,et al.  CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. , 2004, Immunity.

[52]  S. A. van de Pavert,et al.  Lymph sacs are not required for the initiation of lymph node formation , 2009, Development.

[53]  K. Hogquist,et al.  Identification of a novel population of Langerin+ dendritic cells , 2007, The Journal of experimental medicine.

[54]  M. Merad,et al.  Lymph-migrating, tissue-derived dendritic cells are minor constituents within steady-state lymph nodes , 2008, The Journal of experimental medicine.